Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Survival time in dogs with non-treated nasal carcinomas
Not all owners of dogs with malignant nasal tumors agree to perform surgery, radiation or chemotherapy. Less is known about the survival time of dogs receiving no or only palliative therapy. A large and very informative study provides more informations to give to the owners of affected dogs.

the objective of the retrospective study was to evaluate factors associated with survival in dogs with nasal carcinomas that did not receive treatment or received only palliative treatment. 139 dogs with histologically confirmed nasal carcinomas were included.

Medical records, computed tomography images, and biopsy specimens of nasal carcinomas were reviewed.

Only dogs that were not treated with radiation, surgery, chemotherapy, or immunotherapy and that survived > or = 7 days from the date of diagnosis were included.

The Kaplan-Meier method was used to estimate survival time.

Factors potentially associated with survival were compared by use of log-rank and Wilcoxon rank sum tests.

Multivariable survival analysis was performed by use of the Cox proportional hazards regression model.

RESULTS: Overall median survival time was 95 days (95% confidence interval [CI], 73 to 113 days; range, 7 to 1,114 days). In dogs with epistaxis, the hazard of dying was 2.3 times that of dogs that did not have epistaxis.

Median survival time of 107 dogs with epistaxis was 88 days (95% CI, 65 to 106 days) and that of 32 dogs without epistaxis was 224 days (95% CI, 54 to 467 days).

CONCLUSIONS AND CLINICAL RELEVANCE: The prognosis of dogs with untreated nasal carcinomas is poor. Treatment strategies to improve outcome should be pursued.



Source: Rassnick KM, et al (2006): Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003). In: J Am Vet Med Assoc. 2006 Aug 1;229(3):401-6.




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Retrobulbar hematoma following maxillary nerve block in a dog
This clinical report details the development and successful management of a unilateral retrobulbar hemorrhage following maxillary nerve block. Management of this condition requires prompt recognition and treatment to prevent permanent damage to the eye. The cornerstone of treatment is drainage, which rapidly decreases the increased intraorbital and intraocular pressure. To our knowledge, this is the first documentation of this complication in the English language literature and is very useful for daily practice.

  • Tolerability of a rapid-escalation vinblastine-prednisolone protocol in canine mast cell tumours
  • Translaryngeal percutaneous arytenoid lateralization technique in dogsmembers
  • Hypothermia in Dogs and Cats with Uremia
  • Retrospective Study of Feline Exocrine Pancreatic Insufficiency
  • 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology members
  • Dynamic sonography of the metacarpophalangeal digital flexor tendon sheath in horsesmembers
  • Improved survival in patients undergoing pulmonary metastasectomy for sarcomamembers
  • LDE tendon mineralization with concurrent cruciate ligament rupturemembers
  • Role of IL-4 in neoplastic canine mast cellsmembers
  • Cryopreserved platelet concentrate transfusions in 43 dogsmembers
  • CT comparison of intranasal features in brachycephalic and normocephalic dogsmembers
  • Comparison of 2 Doses for ACTH Stimulation Testing in Dogs members


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved